Left Ventricular Unloading Using an Impella CP Improves Coronary Flow and Infarct Zone Perfusion in Ischemic Heart Failure

Data de publicació:

Autors de IIS La Fe

Autors aliens a IIS La Fe

  • Watanabe, S
  • Fish, K
  • Kovacic, JC
  • Bikou, O
  • Leonardson, L
  • Nomoto, K
  • Kapur, NK
  • Hajjar, RJ
  • Ishikawa, K

Grups d'Investigació

Abstract

Background-Delivering therapeutic materials, like stem cells or gene vectors, to the myocardium is difficult in the setting of ischemic heart failure because of decreased coronary flow and impaired microvascular perfusion (MP). The aim of this study was to determine if mechanical left ventricular (LV) unloading with the Impella increases coronary flow and MP in a subacute myocardial infarction. Methods and Results-Anterior transmural myocardial infarction (infarct size, 26.0 +/- 3.4%) was induced in Yorkshire pigs. At 2 weeks after myocardial infarction, 6 animals underwent mechanical LV unloading by Impella, whereas 4 animals underwent pharmacological LV unloading using sodium nitroprusside for 2 hours. LV unloading with Impella significantly reduced end-diastolic volume (-16 +/- 11mL, P=0.02) and end-diastolic pressure (EDP; -32 +/- 23 mm Hg, P=0.03), resulting in a significant decrease in LV end-diastolic wall stress (EDWS) (infarct: 71.6 +/- 14.7 to 43.3 +/- 10.8 kdynes/cm(2) [P=0.02]; remote: 66.6 +/- 20.9 to 40.6 +/- 13.3 kdynes/cm(2) [P=0.02]). Coronary flow increased immediately and remained elevated after 2 hours in Impella-treated pigs. Compared with the baseline, MP measured by fluorescent microspheres significantly increased within the infarct zone (109 +/- 81%, P=0.003), but not in the remote zone. Although sodium nitroprusside effectively reduced LV-EDWS, 2 (50%) of sodium nitroprusside-treated pigs developed profound systemic hypotension. A significant correlation was observed between the infarct MP and EDWS (r(2)=0.43, P=0.03), suggesting an important role of EDWS in regulating MP during LV unloading in the infarcted myocardium. Conclusions-LV unloading using an Impella decreased EDWS and increased infarct MP without hemodynamic decompensation. Mechanical LV unloading is a novel and efficient approach to increase infarct MP in patients with subacute myocardial infarction.

Dades de la publicació

ISSN/ISSNe:
2047-9980, 2047-9980

Journal of the American Heart Association  WILEY

Tipus:
Article
Pàgines:
-
PubMed:
29514806
Factor d'Impacte:
2,517 SCImago
Quartil:
Q1 SCImago

Cites Rebudes en Web of Science: 48

Documents

  • No hi ha documents

Mètriques

Filiacions mostrar / ocultar

Keywords

  • coronary flow; left ventricular unloading; percutaneous left ventricular assist device; perfusion; wall stress

Campos d'Estudi

Projectes associats

APOPTOSIS EN EL RECHAZO AGUDO DEL INJERTO CARDIACO ALOGENICO

Investigador Principal: LUIS ALMENAR BONET

AP-196/10 . 2010

ESTUDIO DE FASE 2, ABIERTO Y DE UN SOLO GRUPO PARA EVALUAR LA EFICACIA, SEGURIDAD Y FARMACOCINÉTICA DE ROVALPITUZUMAB TESIRINA (SC16LD6.5) PARA EL TRATAMIENTO DE TERCERA LÍNEA Y POSTERIORES DE SUJETOS CON CÁNCER DE PULMÓN MICROCÍTICO QUE EXPRESA LA PROTEÍNA 3 AFÍN A DELTA RECIDIVANTE O RESISTENTE (TRINITY).

Investigador Principal: ÓSCAR JOSÉ JUAN VIDAL

SCRX001-002 . 2016

APNEA DE SUEÑO, ARRITMIAS Y REMODELADO CARDIACO INVERSO EN PACIENTES CON INSUFICIENCIA CARDIACA.

Investigador Principal: MARÍA JOSÉ SANCHO-TELLO DE CARRANZA

ICSY03 . 2017

ESTUDIO ALEATORIZADO, DOBLE CIEGO, CONTROLADO CON PLACEBO PARA INVESTIGAR LA EFICACIA Y LA SEGURIDAD DE MEPOLIZUMAB EN EL TRATAMIENTO DE ADOLESCENTES Y ADULTOS CON SÍNDROME HIPEREOSINOFÍLICO GRAVE.

Investigador Principal: GUILLERMO SANZ SANTILLANA

200622 . 2017

CONTROL ESTRATÉGICO PARA LA OPTIMIZACIÓN DE LA RESPUESTA A LA TERAPIA DE RESINCRONIZACIÓN CARDÍACA (STRATEGIC MANAGEMENT TO OPTIMIZE RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY) (SMART-CRT STUDY).

Investigador Principal: MARÍA JOSÉ SANCHO-TELLO DE CARRANZA

C2067 . 2017

ESTUDIO CLINICO DE FASE II, ALEATORIZADO, BASADO EN BIOMARCADORES, EN PACIENTES CON LEUCEMIA MIELOIDE AGUDA (LMA) RECIDIVANTE O RESISTENTE DE DEPENDENCIA DE MCL-1 .30%.

Investigador Principal: PAU MONTESINOS FERNÁNDEZ

TPI-ALV-201 . 2018

ESTUDIO ALEATORIZADO, DOBLE CIEGO, CONTROLADO CON PLACEBO, DE BÚSQUEDA DE DOSIS PARA EVALUAR LA EFICACIA Y LA SEGURIDAD DE PADSEVONIL COMO TRATAMIENTO ADYUVANTE DE CRISIS FOCALES EN SUJETOS ADULTOS CON EPILEPSIA FÁRMACORRESISTENTE.

Investigador Principal: VICENTE ENRIQUE VILLANUEVA HABA

EP0091 . 2018

Compartir la publicació